Jin-song Jia

Beijing Key Laboratory Of Cell And Gene Therapy For Hematologic Malignancies
Beijing, 100044, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Hematopoiesis could be improved by correcting aberrant bone marrow macrophages polarization in aplastic anemia patients.

Hematopoiesis could be improved by correcting aberrant bone marrow macrophages polarization in aplastic anemia patients.

Journal: Science China. Life sciences

Published: June 23, 2025

TGF-β inhibition restores hematopoiesis and immune balance via bone marrow EPCs in aplastic anemia.

TGF-β inhibition restores hematopoiesis and immune balance via bone marrow EPCs in aplastic anemia.

Journal: Experimental & molecular medicine

Published: August 19, 2024

A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy.

A complete oral regimen for induction therapy of patients with high-risk APL: An oral etoposide instead of intravenous infusion for cytoreductive chemotherapy.

Journal: British journal of haematology

Published: January 01, 2024

Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.

Comparison of haploidentical-allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study.

Journal: Annals of hematology

Published: October 15, 2022

Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?

Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation?

Journal: Transplantation and cellular therapy

Published: March 03, 2022

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia.

Interferon-α as maintenance therapy can significantly reduce relapse in patients with favorable-risk acute myeloid leukemia.

Journal: Leukemia & lymphoma

Published: July 01, 2021

PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study.

PML-RARA transcript levels at the end of induction therapy are associated with prognosis in non-high-risk acute promyelocytic leukaemia with all-trans retinoic acid plus arsenic in front-line therapy: long-term follow-up of a single-centre cohort study.

Journal: British journal of haematology

Published: May 08, 2021

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy.

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy.

Journal: Chinese medical journal

Published: October 01, 2019

Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations.

Minimal residual disease detected by multiparameter flow cytometry is complementary to genetics for risk stratification treatment in acute myeloid leukemia with biallelic CEBPA mutations.

Journal: Leukemia & lymphoma

Published: February 19, 2019

Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission.

Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 28, 2018

Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia.

Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia.

Journal: Bone marrow transplantation

Published: May 13, 2018

Oral arsenic and all-trans retinoic acid for high-risk acute promyelocytic leukemia.

Oral arsenic and all-trans retinoic acid for high-risk acute promyelocytic leukemia.

Journal: Blood

Published: February 17, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026